Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Immunogenetics. 2013 Feb 17;65(5):387–396. doi: 10.1007/s00251-013-0678-9

Table 1.

Analysis of mutations in VL segments of medaka immunoglobulin light chain coding ESTs

EST Germline
VL
Mutations
FR FR-PMb Mutations
CDR CDR-PMb
FR1 FR2 FR3 R:Sa CDR1 CDR2 R:Sa
OLOVA49021 V3-2 0 3 1 3:1 0.115 2 1 1:2 0.299
OLKI56H12 V5-2 3 0 1 2:2 0.000 5 0 4:1 0.001
OLSP40B17 V4-2 0 2 2 1:3 0.003 1 2 1:2 0.260
OLGI48J17 V4-2 1 7 2 5:5 0.002 2 0 2:0 0.145
OLSP42K18 V6b-2 4 3 1 2:6 0.000 5 4 4:5 0.019
OLKI20G22 V10-2 0 1 0 1:0 0.081 3 0 0:3 0.699
OLKI23P18 V10-2 0 2 0 2:0 0.164 3 0 0:3 0.735
OLKI35K02 V10-2 0 1 0 1:0 0.081 3 0 0:3 0.699
OLSP13L18 V7-3 2 0 0 1:1 0.055 2 0 1:1 0.141
OLKI53D04 V10d-3 2 5 5 3:9 0.003 0 0 0:0 0.860
OLKI61N09 V11-3 4 2 2 3:5 0.045 1 0 1:0 0.512
OLKI33H22 V12-3 0 1 2 1:2 0.001 4 2 5:1 0.001
OLKI30J18 V13-3 0 0 2 2:0 0.774 0 0 0:0 0.576
a

Number of replacement (R) mutations vs. silent (S) mutations found in each VL subregion. The CDR3 and FR4 were not included in the analysis of mutations

b

PM value, probability calculated by multinomial distribution model that excess (for CDR) or scarcity (for FR) of mutations occurred by chance. The level of significance was P≤0.05